---
title: "RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296620309.md"
description: "RenovoRx, Inc., a biotech company based in Mountain View, California, has successfully regained compliance with the Nasdaq Stock Market LLC's minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company, trading under the symbol RNXT, focuses on developing targeted oncology therapies and distributing their patented FDA-cleared drug delivery device, RenovoCath®. This recent development was announced on August 21, 2026, signifying the company's commitment to meeting market standards and maintaining its foothold in the industry."
datetime: "2026-08-21T12:31:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296620309.md)
  - [en](https://longbridge.com/en/news/296620309.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296620309.md)
generator: "portal-rs"
---

# RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

RenovoRx, Inc., a biotech company based in Mountain View, California, has successfully regained compliance with the Nasdaq Stock Market LLC's minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company, trading under the symbol RNXT, focuses on developing targeted oncology therapies and distributing their patented FDA-cleared drug delivery device, RenovoCath®. This recent development was announced on August 21, 2026, signifying the company's commitment to meeting market standards and maintaining its foothold in the industry.

### Related Stocks

- [RNXT.US](https://longbridge.com/en/quote/RNXT.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [RenovoRx cites peer-reviewed case series on TAMP gemcitabine delivery in locally advanced pancreatic cancer](https://longbridge.com/en/news/300684895.md)
- [RNXT: Strong commercial growth and clinical data position RenovoCath for major oncology market impact](https://longbridge.com/en/news/298948734.md)
- [GRAPHIC-Take Five: AI trade meets the Fed](https://longbridge.com/en/news/302836715.md)
- [Western Digital Q1 Revenue Surges 55% YoY, Shares Drop Nearly 7%: Can $330 Support Hold?](https://longbridge.com/en/news/302840204.md)
- [BE: Revenue rose 138% YoY as margins expanded and FY2026 guidance was raised again](https://longbridge.com/en/news/302787538.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**